ADAG · Adagene
AI read · Good for ADAG
The AI's read
This moves ADG138 into human testing and adds progress to Adagene's cancer-drug pipeline. The study has not shown whether the treatment works or avoids harm, so its promise remains unproven.
Adagene has begun human testing of ADG138, a positive step for its cancer-drug pipeline. The study has not shown whether the treatment works or avoids harm.
This moves ADG138 into human testing and adds progress to Adagene's cancer-drug pipeline. The study has not shown whether the treatment works or avoids harm, so its promise remains unproven.
Follow Adagene (ADAG) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ADAG